Brief: Bidi Vapor Wins Merits Case Against FDA, Kaival Brands Anticipates Revenue Growth From Decision
25/08/2022 14:18
Aug 25 (Reuters) - Kaival Brands Innovations Group Inc
KAVL.O :
* BIDI VAPOR WINS MERITS CASE AGAINST FDA; KAIVAL BRANDS
ANTICIPATES REVENUE GROWTH FROM DECISION
* KAIVAL BRANDS INNOVATIONS GROUP INC - U.S. COURT OF
APPEALS FOR
ELEVENTH CIRCUIT HAS RULED 2-1 IN BIDI VAPOR'S FAVOR
* KAIVAL BRANDS INNOVATIONS GROUP INC - RULING REVERSES MDO
&
ALLOWS BIDI VAPOR TO CONTINUE TO MARKET ALL FLAVOR VARIETIES OF
BIDI STICK IN U.S.
Source text for Eikon: ID:nGNXqJshG
Further company coverage: KAVL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kaival Brands Innovations
See all newsCo And Delta Corp Terminate Business Combination Agreement - SEC Filing
Brief: Kaival Brands Innovations Group Inc - Enters Equity Distribution Agreement With Maxim - SEC Filing
Brief: Kaival Brands Innovations Group Inc Files For Mixed Shelf Offering Of Up To $100 Million
Brief: Delta Corp Enters Into Definitive Merger Agreement With Kaival Brands
Brief: Kaival Brands Innovations Group On Sept 16, Got Notice From Nasdaq On Co's Failure To Satisfy A Continued Listing Rule Or Standard